Advertisement

Topics

$67M in funding granted to Amplyx for anti-fungal drug study

05:37 EDT 2 Aug 2017 | SmartBrief

A $67 million Series C funding round will allow San Diego-based Amplyx Pharmaceuticals to advance into a pivotal midstage stu -More

Original Article: $67M in funding granted to Amplyx for anti-fungal drug study

NEXT ARTICLE

More From BioPortfolio on "$67M in funding granted to Amplyx for anti-fungal drug study"

Quick Search
Advertisement